Island Pharmaceuticals Boosts Galidesivir Supply Amid Ebola Outbreak, Shares Up 4%

Like
Comment
Favorite

Island Pharmaceuticals Boosts Galidesivir Supply Amid Ebola Outbreak, Shares Up 4%

MT Newswires Live08:43

Island Pharmaceuticals (ASX:ILA) commissioned an additional production campaign of good manufacturing practice (GMP) grade antiviral drug Galidesivir with contract manufacturer PI Health Sciences, according to a Friday Australian bourse filing.

The manufacturing is expected to be completed in the fourth quarter, providing up to about 800 treatment courses, per the filing.

The company said the additional supply comes as the ongoing Ebola virus Bundibugyo strain outbreak continues to spread rapidly across Central Africa, with Galidesivir expected to be deployed in Uganda during the year, providing an opportunity to generate human efficacy, safety and virological data during an active outbreak.

The company's shares rose 4% in recent Friday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2661532952?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-21 08:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2661532952","market":"fut","top_or_hot":-1,"title":"Island Pharmaceuticals Boosts Galidesivir Supply Amid Ebola Outbreak, Shares Up 4%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/ILA.AU\">Island Pharmaceuticals</a> (ASX:ILA) commissioned an additional production campaign of good manufacturing practice (GMP) grade antiviral drug Galidesivir with contract manufacturer PI Health Sciences, according to a Friday Australian bourse filing.</p><p>The manufacturing is expected to be completed in the fourth quarter, providing up to about 800 treatment courses, per the filing.</p><p>The company said the additional supply comes as the ongoing Ebola virus Bundibugyo strain outbreak continues to spread rapidly across Central Africa, with Galidesivir expected to be deployed in Uganda during the year, providing an opportunity to generate human efficacy, safety and virological data during an active outbreak.</p><p>The company's shares rose 4% in recent Friday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Island Pharmaceuticals Boosts Galidesivir Supply Amid Ebola Outbreak, Shares Up 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIsland Pharmaceuticals Boosts Galidesivir Supply Amid Ebola Outbreak, Shares Up 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-21 08:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/ILA.AU\">Island Pharmaceuticals</a> (ASX:ILA) commissioned an additional production campaign of good manufacturing practice (GMP) grade antiviral drug Galidesivir with contract manufacturer PI Health Sciences, according to a Friday Australian bourse filing.</p><p>The manufacturing is expected to be completed in the fourth quarter, providing up to about 800 treatment courses, per the filing.</p><p>The company said the additional supply comes as the ongoing Ebola virus Bundibugyo strain outbreak continues to spread rapidly across Central Africa, with Galidesivir expected to be deployed in Uganda during the year, providing an opportunity to generate human efficacy, safety and virological data during an active outbreak.</p><p>The company's shares rose 4% in recent Friday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7096","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2661532952","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2661532952","pubTimestamp":1787272988,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Island Pharmaceuticals  commissioned an additional production campaign of good manufacturing practice  grade antiviral drug Galidesivir with contract manufacturer PI Health Sciences, according to a Friday Australian bourse filing.The manufacturing is expected to be completed in the fourth quarter, providing up to about 800 treatment courses, per the filing.The company said the additional supply comes as the ongoing Ebola virus Bundibugyo strain outbreak continues to spread rapidly across Central Africa, with Galidesivir expected to be deployed in Uganda during the year, providing an opportunity to generate human efficacy, safety and virological data during an active outbreak.The company's shares rose 4% in recent Friday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7096":"制药","ILA.AU":"ISLAND PHARMACEUTICALS LTD"},"translate_title":"Island Pharmaceuticals 在埃博拉疫情期间增加加利地韦供应，股价上涨 4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ILA.AU":1},"content_text":"Island Pharmaceuticals (ASX:ILA) commissioned an additional production campaign of good manufacturing practice (GMP) grade antiviral drug Galidesivir with contract manufacturer PI Health Sciences, according to a Friday Australian bourse filing.The manufacturing is expected to be completed in the fourth quarter, providing up to about 800 treatment courses, per the filing.The company said the additional supply comes as the ongoing Ebola virus Bundibugyo strain outbreak continues to spread rapidly across Central Africa, with Galidesivir expected to be deployed in Uganda during the year, providing an opportunity to generate human efficacy, safety and virological data during an active outbreak.The company's shares rose 4% in recent Friday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}